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Abstract (max. 250 words) 
 
Maintaining a positive iron balance is essential for female athletes to avoid the 
effects of iron deficiency and anaemia and to maintain or improve performance.  A 
major function of iron is in the production of the oxygen and carbon dioxide carrying 
molecule, haemoglobin via erythropoiesis. Iron balance is under the control of a 
number of factors including the peptide hormone hepcidin, dietary iron intake and 
absorption, environmental stressors (e.g. altitude), exercise, menstrual blood loss 
and genetics.  Menstruating females, particularly those with heavy menstrual 
bleeding are at an elevated risk of iron deficiency.  Haemoglobin concentration [Hb] 
and serum ferritin (sFer) are traditionally used to identify iron deficiency, however, in 
isolation these may hav  limited value in athletes due to: 1. the effects of fluctuations 
in plasma volume in response to training or the environment on [Hb], 2. the influence 
of inflammation on sFer and 3. the absence of sport, gender and individually specific 
normative data. A more detailed and longitudinal examination of haematology, 
menstrual cycle pattern, biochemistry, exercise physiology, environmental factors 
and training load can offer a superior characterisation of iron status and help to direct 
appropriate interventions that will avoid iron deficiency or iron overload.  
Supplementation is often required in iron deficiency; however, nutritional strategies to 
increase iron intake, rest, and descent from altitude can also be effective and will 
help to prevent future iron deficient episodes.  In severe cases or where there is a 
time-critical need, such as a major championships, iron injections may be 
appropriate.  
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Introduction 
 
  Iron is a component of multiple cellular functions and physiological systems and is 
therefore essential for human health and athletic performance, yet iron deficiency is 
one of the most common deficiencies in sport.  Athlete’s iron requirements may be 
higher due to the increased erythropoietic drive caused by regular exercise.  
Furthermore, footstrike haemolysis, gastro-intestinal bleeding, exercise-induced 
inflammation, anti-inflammatory drug use and environmental factors such as hypoxia 
may all influence iron metabolism in athletes.  The female athlete is at a particular 
risk of iron deficiency due to menstruation and screening for iron deficiency is widely 
recommended for all athletes (DellaValle, 2013).  The effects of the female hormones 
on iron metabolism in athletes are largely unknown.     
 
  Iron deficiency anaemia requires medical intervention; however, increasingly sport 
scientists and nutritionists are measuring, monitoring and attempting to optimise iron 
status in athletes since it is closely connected to endurance performance (Montero et 
al., 2017; Pedlar et al., 2013; Peeling et al., 2007). Individuals can respond to iron 
treatment even when they are within a normal clinical reference range and vice-
versa: athletes may ostensibly be iron deficient and yet iron treatment is ineffective 
(Burden, Pollock, et al., 2015; Pedlar et al., 2013; Wachsmuth, Aigner, Volzke, Zapf, 
& Schmidt, 2015). Those athletes with the most severe iron deficiency are most likely 
to respond positively to treatment (Wachsmuth et al., 2015). 
 
  Some discrepancy in the literature exists over the appropriate identification and 
treatment of iron deficiency in sport and there are no widely used guidelines for 
clinicians and dieticians to follow although there have been a number of relevant 
reviews (Archer & Brugnara, 2015; Clenin et al., 2015; Latunde-Dada, 2013).  The 
present review considers research pertaining to the female athlete and provides 
recommendations for identifying and correcting iron deficiency.  Specific scenarios 
where female athletes are at risk of iron deficiency are discussed.    
 
Iron balance and exercise performance 
 
  High performing endurance athletes are characterised by a high aerobic capacity 
together with a high aerobic power output or velocity. This phenotype is achieved via 
a number of physiological adaptations that promote the delivery of oxygen-rich blood 
to the musculature including: increased cardiac size and function, increased blood 
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volume or red cell mass, and enhanced off-loading of oxygen within the muscle 
tissue (Mairbaurl & Weber, 2012; Montero et al., 2017; Schmidt & Prommer, 
2010).      
 
  Haemoglobin, carried in the red blood cell, is a globular protein pigment molecule 
containing a non-protein heme group in its centre, carrying the iron ion at the site of 
oxygen binding.  Haemoglobin is carried in red blood cells which are produced and 
cleared at a rate of approximately 2 million per second (Higgins, 2015), thus total 
haemoglobin mass (tHbmass), a primary determinant of maximal oxygen uptake (
) (Schmidt & Prommer, 2010), is fundamentally reliant upon adequate iron 
stores. Iron is also a requisite component of cytochromes and enzymes involved in 
electron transport within the mitochondria. A reduction in iron stores may therefore 
impact upon the capacity for both oxygen transport and utilisation, lead to fatigue, or 
cause under-performance.  Further, since iron is essential for brain development and 
cognitive performance (Murray-Kolb & Beard, 2007), iron deficiency could affect 
motivation, concentration and decision-making, also impacting upon exercise 
performance. 
 
  Appropriate identification and correction of iron deficiency can have a significant 
impact on athlete performance and wellbeing in endurance sports and team sports 
with a significant endurance component.  Importantly, there is no evidence that 
supra-normal iron levels enhance performance beyond a placebo effect.  On the 
contrary, there is evidence and concern over the negative effects of iron overload 
(Zoller & Vogel, 2004; Zotter et al., 2004) due to the potential for the production of 
damaging free radicals from free iron.  Iron is a transition metal and has 5 oxidation 
states. Through the Haber–Weiss reactions, highly reactive OH radicals are 
produced, causing lipid peroxidation, and the appearance of malondialdehyde and 
thiobarbituric acid (TBARS) reactive substances.  Although human studies are rare, 
in various animal studies of iron overload, elevations in TBARS have been found in 
the liver, kidney and plasma in response to iron administration (Zhuang, Han, & 
Yang, 2014).  A link between iron overload and other diseases including cancer  has 
also been reported (Mallory & Kowdley, 2001).  Thus, any intervention should only be 
aimed at normalising iron status.  
 
  The challenge therefore is to maintain an appropriate iron status, avoiding the 
negative consequences of either iron toxicity or iron deficiency. Environmental 
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factors, exercise volume and intensity, diet and supplementation are under the 
control of the athlete, whereas genetics, menstrual blood losses, the rate of iron 
absorption and compensatory physiological mechanisms are not.  The factors 
affecting iron balance as it pertains to athletic performance can be described with the 
conceptual formula in Table 1.  With an awareness of the factors influencing iron 
balance, Sports Science and Sports Medicine practitioners can appropriately monitor 
and advise athletes.  Figure 1 provides a timeline with a number of scenarios known 
to affect iron balance, illustrating the importance of context at the time of assessing 
iron status.  
 
Control of iron status 
The regulation of iron absorption, storage and the regulation of erythropoiesis is 
under the control of iron protein regulators and hypoxia inducible factors respectively 
(Kuhn, 2015). Iron absorption is under the control of the peptide hormone hepcidin 
which was only relatively recently discovered (Nemeth et al., 2004).  Briefly, hepcidin 
is secreted in the liver and increases in response to iron overload (Burden, Morton, 
Richards, Whyte, & Pedlar, 2015) or inflammation, shutting down iron absorption via 
ferroportin.  Conversely, hepcidin decreases in anaemia, promoting iron absorption.  
Since exercise results in an inflammatory response, it can transiently increase 
hepcidin (Burden, Pollock, et al., 2015), potentially reducing the capacity to absorb 
iron.  Therefore, heavy and frequent exercise training bouts may put the athlete at 
risk of iron deficiency although more studies are needed to understand the 
longitudinal effects of exercise upon hepcidin.  Recent evidence suggests that during 
recovery from marathon training iron status improves (Pedlar et al., 2017), thus, rest 
may be an effective means of correcting iron deficiency although more studies are 
needed.    
 
Altitude training 
Altitude is known to have a profound impact upon iron status and therefore athletes 
travelling to altitude should consider the need for iron supplementation.  The 
reproducible effect of a transition to altitude upon iron metabolism has been clearly 
demonstrated in athletes.  In hypoxia, erythropoietin increased and sFer decreased 
while a slow increase in tHbmass occurred over 3 weeks at a simulated altitude of 
3000m in male and female endurance athletes (Robertson et al., 2010). Furthermore, 
in an analysis of data from the Australian Institute of Sport database (n=147 
athletes), iron deficient athletes provided with iron supplementation while resident in 
normobaric hypoxia (simulated altitude), demonstrated the greatest increase in 
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tHbmass (Garvican-Lewis et al. 2016). Conversely, upon return to sea level, iron 
status improves, causing a rise in ferritin (Robertson et al. 2010).  Thus, removing 
the hypoxic stimulus may correct an imbalance between iron availability and 
erythropoietic drive.  The mechanisms responsible for this shift to storage of iron may 
also include the destruction of new red blood cells (neocytolysis; Alfey, Rice, Udden 
& Driscoll, 1997), or premature clearance older cells (elevated clearance threshold; 
Higgins, 2015), however, both these mechanisms remain to be proven in athletes.  
Studies specifically investigating differences between males and females in altitude 
and post-altitude responses are lacking.  
   
Menstruation 
Menstruating women lose approximately 1 mg.day-1 of iron when bleeding. This may 
be higher in heavy menstrual bleeding (HMB), where blood loss is estimated to be 5-
6 times greater (Napolitano et al., 2014).  HMB has recently been found to be 
prevalent in athletes at all levels, affecting 1 in 3 (Bruinvels, Burden, Brown, 
Richards, & Pedlar, 2016).  An inflammatory process drives the majority of the 
normal physiological responses within the reproductive system: Cytokine expression 
varies through the course of the menstrual cycle, peaking during menstruation 
(Bertone-Johnson et al., 2014). The increased levels of inflammatory mediators have 
the potential to increase hepcidin release in the liver, reducing iron absorption and 
further increasing the risk of iron deficiency at this time.  Once the bleed commences, 
hepcidin decreases to promote iron absorption (Angeli et al., 2016), rebounding later 
in the cycle. Further research is required to establish variation in hepcidin production 
through the menstrual cycle in athletes.  
 
Pregnancy 
Pregnancy is another condition in which iron intake is often insufficient due to rapid 
growth. The estimated worldwide prevalence of IDA in pregnancy is 15-20% (Cao & 
O'Brien, 2013).  Enlargement of maternal erythrocyte mass, the formation of foetal 
tissue and the development of foetal iron stores increase maternal iron demand, 
elevating iron deficiency risk. Initially, in early pregnancy, the absence of 
menstruation means that iron status may not be compromised. However, as foetal 
iron demand increases as pregnancy progresses, susceptibility to iron deficiency is 
elevated (Cao & O'Brien, 2013). During the third trimester, daily iron requirements 
are 3-8 mg.d-1 (Viteri, 1994). Reliability of iron status measurement is questionable 
during pregnancy, particularly in the third trimester, where there is a pregnancy-
induced haemodilution (Viteri, 1994).  Clearly there are many other considerations for 
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athletes choosing to exercise during pregnancy (see Erdener & Budgett, 2016 and 
other recent reviews).  
   
The effect of iron deficiency on aerobic exercise performance 
 
  Iron deficiency anaemia (IDA) has a profound effect on performance, depending on 
the severity, however, the effect of iron deficient non-anaemia (IDNA) is less clear.   
DellaValle and Haas (DellaValle & Haas, 2011) reported a relationship between sFer 
and 2 km time trial performance amongst female collegiate rowers at the beginning 
of a competition season, with those athletes who were IDNA reporting a 21s slower 2 
km time trial times compared to those who were iron replete.  Iron deficiency may 
also influence total training load, for example, IDNA female collegiate rowers 
performed significantly less weekly mileage than their iron replete counterparts 
(Dellavalle & Haas, 2012). Furthermore, several iron supplementation studies have 
shown improvement in indices of aerobic capacity following treatment in female 
athletes (Brownlie, Utermohlen, Hinton, & Haas, 2004; Friedmann, Weller, Mairbaurl, 
& Bartsch, 2001; Hinton, Giordano, Brownlie, & Haas, 2000; Hinton & Sinclair, 2007; 
Magazanik et al., 1991; Wachsmuth et al., 2015; Zhu & Haas, 1998), suggesting that 
an initial IDNA was compromising performance.  
 
  However, there are also several studies that have reported no effects of iron 
treatments on exercise performance in femal  IDNA endurance athletes (Blee, 
Goodman, Dawson, & Stapff, 1999; Burden, Pollock, et al., 2015; Garvican et al., 
2014; Peeling et al., 2007; Radjen et al., 2011; Tsalis, Nikolaidis, & Mougios, 2004); 
and no direct association has been proven between sFer and performance, even 
when <30 μg.L-1 
 
  A number of variables may be responsible for these discrepancies as follows: The 
variation in sFer cut-off values used to identify iron deficiency; the variety of 
measures used to assess aerobic capacity and endurance performance; The 
duration of studies, which may not have provided enough time for an effect; the 
variation in the exercise stimulus experienced during iron therapy; the type of therapy 
and dosing protocol; the performance level of the participants.   
 
Identifying iron deficiency 
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  Symptoms of fatigue indicate potential iron deficiency.  The gold standard for 
measuring iron stores is a bone marrow biopsy, but since this is not practical in 
athletes, and the interpretation of this test is plagued by a wide variability (Stancu et 
al., 2010) we recommend alternative methods based on blood testing. Serum ferritin 
(sFer) has been used as a biomarker of iron stores since a direct correlation between 
plasma ferritin and whole body iron was established in the 1970’s (Jacobs & 
Worwood, 1975).  Periodic screening sFer and [Hb] is recommended for all athletes 
by the International Olympic Committee (Ljungqvist et al., 2009).    
 
  Broadly, there are three stages of iron deficiency; firstly, a depletion of iron stores 
(i.e. a reduced serum ferritin) without any evidence of a haematological 
consequence; secondly, early signs of iron deficiency impacting upon haematological 
markers (for example, haemoglobin towards the lower end of the range, an elevated 
percentage microcytic reticulocytes and hypochromic reticulocytes), but these 
markers remaining within reference ranges and; finally, iron deficiency anaemia 
characterised by multiple markers of low iron stores and haematological variables 
outside of reference ranges (reviewed by Archer et al.; (Archer & Brugnara, 2015)). 
 
  Haemoglobin concentration ([Hb]) and serum ferritin (sFer) are typically used 
together, however, the interpretation of both measures is problematic because of the 
variability in individual [Hb] and sFer data such that they may not adequately reflect 
whole body iron stores.  The clinical range provided by the laboratory may be of 
limited relevance to an athlete.  [Hb] and sFer each have their own biological set 
points dependent on sex, sport, age, genes, menstrual blood loss, dietary and 
environmental factors (Archer & Brugnara, 2015).  [Hb] can be low because of a 
normal plasma volume expansion caused by exercise, posture or acclimatisation 
(Garvican-Lewis et al., 2014).  Conversely, [Hb] may reside within the normal clinical 
range, but tHbmass may not be optimised (Wachsmuth et al., 2015).  sFer is an 
acute phase protein and can be artificially raised in the presence of infection or 
inflammation (Moore, Ormseth, & Fuchs, 2013).  Finally, there is little consensus 
amongst clinicians or researchers on a definitive clinical cut point for sFer.  A range 
of values for sFer have been applied in the literature to define iron deficiency ranging 
from 7 µg.L-1 (Tsalis et al., 2004) to 40 µg.L-1 (Burden, Pollock, et al., 2015; Garvican 
et al., 2014; Peeling et al., 2007), whereas a [Hb] of 12.0 g.dL-1 has been fairly 
consistently applied.   
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  A closer consideration of the red blood cell morphology provides variables such as 
mean corpuscular haemoglobin (MCH), mean cell volume (MCV) and reticulocyte 
haemoglobin concentration (CHr or Ret-He) and this may have diagnostic utility for 
certain types of anaemia or latent anaemia.  Additional biochemistry markers 
including serum transferrin receptor, serum iron, serum transferrin and transferrin 
saturation may also assist with the identification of iron deficiency (Archer & 
Brugnara, 2015).  Assessment of total haemoglobin mass via the carbon monoxide 
rebreathing technique is also gaining favour as a tool for identifying iron deficiency 
and assessing responses to treatment in athletes (Garvican, Lobigs, Telford, Fallon, 
& Gore, 2011; Wachsmuth et al., 2015).  
 
  A diagnosis of IDNA can only be confirmed definitively once a positive 
haematological response to treatment is observed and this approach has been 
advocated in recent studies (Garvican et al., 2011; Wachsmuth et al., 2015).   
 
Correcting iron deficiency 
 
  The most appropriate course of action depends on the data available and the 
severity of the iron deficiency.  A review of dietary iron intake may be enough to 
improve iron status or to avoid IDNA and all female athletes should consider their 
dietary iron intake and ensure regular daily consumption of iron rich foods. Likewise, 
an understanding of foods that chelate iron and inhibit absorption, such as phytates 
and polyphenols, will help to ensure optimal dietary iron intake (see Dietary Iron 
section). 
 
  Where more severe iron deficiency exists and IDA is clearly present ([Hb] <12.0 
g.dL-1 and tHb-mass is trending lower than would be considered normal for that 
individual), iron treatment should be instigated under the guidance of a medical 
doctor. The response to the treatment should be tracked with measurements of red 
cell indices and tHb-mass where possible (notwithstanding that facilities for the 
carbon monoxide rebreathing test are not widely available). It is reasonable to repeat 
tests as often as 2-week intervals to plot a positive response to treatment. If a clear 
improvement in tHbmass is observed, the diagnosis of iron deficiency can be 
accepted and regular monitoring should continue.  A process for addressing iron in 
the context of an athlete reporting with fatigue is outlined in Figure 2.    
 
Effect of Iron Treatment on Iron Status 
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  Supplementing athletes with iron will increase sFer, at least transiently. Oral iron 
supplementation in doses ranging from 40-400 mg.day-1, for 6-24 weeks and both IM 
and IV injections have all resulted in significantly improved sFer values (Burden, 
Morton, et al., 2015). For individuals with IDA, iron treatments will increase sFer, tHb-
mass and red cell indices resulting in an improved aerobic power and these indices 
will be maintained providing the cause for the anaemia is identified and treated.  Yet 
when individuals identified as IDNA are treated with IV iron the initial rise in ferritin 
will be present for only a number of weeks, after which sFer may return to pre-
treatment levels (Pedlar et al., 2013) and no change in haematological or 
performance indices may have occurred (Burden, Pollock, et al., 2015).  Longitudinal 
monitoring of iron status gives the practitioner the best chance of optimising tHbmass 
and avoiding IDA or iron overload.   
 
  Haemoglobin concentration (<120 g.L-1) is consistently used to differentiate between 
anaemic and non-anaemic states but as a concentration measurement it is 
influenced by changes in plasma volume (PV), meaning the pre-analytics of the 
sample are crucial to the validity and reliability of the measure. A measurement of 
tHb-mass is independent of changes to PV and a more stable measurement than 
[Hb] (Schmidt & Prommer, 2010). A mean increase in tHbmass of 11% was 
demonstrated in IDA athletes following 12 weeks of oral supplementation 
(Wachsmuth et al., 2015). Furthermore, 2.7% and 1.9% improvements in tHb-mass 
have been reported 6 and 8 weeks following IV iron treatment without a change in 
[Hb] (Garvican et al., 2014). Therefore, tHb-mass appears to be a more sensitive and 
effective measure than [Hb].  However, caution should be taken as the typical 
measurement error associated with the CO rebreathing technique is 2.2% (Gore, 
Hopkins, & Burge, 2005) and annual oscillations in tHb-mass of 4.6% have been 
observed in athletes (Schmidt & Prommer, 2010). Therefore, interpretations of small 
increases in tHb-mass following iron treatment, such as those observed in IDNA 
athletes should be made cautiously and it is recommended that multiple tHb-mass 
measurements are used.  
 
Effect of Iron Treatment on Performance in IDNA athletes 
   A number of studies have shown aerobic power to be unchanged following iron 
treatment in IDNA athletes (Blee et al., 1999; Burden et al., 2015; Peeling et al., 
2007; Radjen et al., 2011; Tsalis et al., 2004), yet one of the few studies to 
investigate IV treatments for endurance athletes, did find a likely significant 
improvement in V O2max from 59.0 ± 10.8 ml
.kg-1.min-1 to 61.7 ± 6.8 ml.kg-1.min-1 
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following IV iron but not oral iron supplementation (Garvican et al., 2014). This study 
implies that iron treatments are effective for IDNA athletes and that IV treatments are 
more effective than oral supplements but the findings are limited by the lack of a 
control group. A randomised control trial examining the efficacy of a single 500 mg IV 
treatment showed no pre-to-post treatment changes in V O2max, vV O2max, running 
economy, speeds at 2 and 4 mmol.L-1 blood lactate, or time to exhaustion, 
suggesting that IDNA had no effect on aerobic power or other laboratory measures 
that are commonly used to evaluate endurance athletes (Burden, Pollock, et al., 
2015).  It is possible these athletes were not iron deficient in the first place, 
particularly given that there were also no changes in red cell indices or tHb-mass. 
Nevertheless, sports science and medicine practitioners should be mindful that the 
effects of iron treatments are not be limited to a haematological response. Increased 
VO2max following iron treatment despite normal [Hb] has been reported (DellaValle & 
Haas, 2014; Friedmann et al., 2001; Hinton et al., 2000; Hinton & Sinclair, 2007; 
Magazanik et al., 1991; Zhu & Haas, 1998), which might be explained by a non-
haem effect, influencing oxygen utilisation rather than oxygen transport. Finch et al. 
(Finch et al., 1976) proposed that iron deficiency produces a mitochondrial 
abnormality resulting in impairment in oxidative phosphorylation and electron 
transport, following investigations into the influence of iron status and [Hb] in 
exercising rats. Unfortunately, there have been very few studies investigating the 
effects of IDNA on mitochondrial function in human subjects, particularly in athletes, 
probably because a muscle biopsy is required.  
 
Dietary iron  
 
  Cross sectional studies show an association between poor dietary iron intake and 
iron deficiency (Malczewska, Raczynski, & Stupnicki, 2000).  Iron is contained in a 
variety of food sources that can be classified into ‘heme’ and ‘non-heme’. The most 
readily absorbed form of iron is heme iron derived from animal meat, especially red 
meat. Poultry and seafood also contain reasonable amounts of heme iron.  
Therefore, vegetarians are at risk of iron deficiency (Venderley & Campbell, 2006) in 
addition to a host of other nutrient deficiencies. Athletes with Celiac disease may 
have compromised iron absorption (Mancini, Trojian, & Mancini, 2011).  Risk of iron 
overload from the diet is extremely low.  Rate of iron absorption from the gut 
measured using radioiron tracers was found to be proportional to serum ferritin at 
levels below 60mg.L-1 in healthy men consuming an iron rich diet (Hallberg, Hultén, & 
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Gramatkovski, 1997).  Above 60mg.L-1, iron absorption was negligible, suggesting 
that it is difficult to achieve iron overload from excessive dietary iron intake.   
 
  Although few studies exist that test iron repletion strategies using food alone (i.e. no 
supplements or injections), it is widely accepted that assessing dietary iron intake 
from non-heme and particularly heme sources is the first step in prevention of, and 
correction of iron deficiency and also forms a long term strategy for prevention of 
future iron deficient episodes.  However, dietary iron is also poorly absorbed which, 
may be a consequence of the up-regulation of hepcidin following the post exercise 
inflammatory response, blocking gastrointestinal iron absorption (Nemeth et al., 
2004). The result is a potential repletion period of between 3-6 months, which 
constitutes a large portion of an athlete's training year and would be unwelcome 
given that iron deficiency may prevent athletes from coping with the required training 
load (Dellavalle & Haas, 2012).  
 
  A number of factors are known to facilitate iron absorption in the gut including 
vitamin C (Reddy, Hurrell, & Cook, 2000), alpha and beta-carotene (Garcı́a-Casal et 
al., 1998) whereas phytic acid, certain polyphenols, phosphorous and calcium may 
all inhibit iron absorption (Reddy et al., 2000).  Calcium supplementation may also 
reduce iron absorption (Minihane & Fairweather-Tait, 1998).  However none of these 
have been specifically studied in athletes. Additionally, a number of other foods and 
drugs may compromise iron absorption (see Armah, Carriquiry, Sullivan, Cook, & 
Reddy (2013) and Clenin et al. (2015) for comprehensive reviews): Bran and other 
wheat products contain phytates (organic polyphosphates) which bind iron and 
reduce its absorption; Antacid therapy increased gastric pH and reduces iron 
absorption; Non-steroidal anti-inflammatory drug use may promote intestinal iron loss 
via microscopic bleedings. 
 
Oral Iron supplementation 
 
  Recent data suggests that up to 79% of elite athletes use iron supplements 
(Bruinvels et al., 2016).  Supplementation is recommended where iron deficiency is 
suspected, with ongoing monitoring to avoid unnecessary supplementation.         
Although iron supplementation is considered safe, the effect of long-term iron 
supplement use is not known. However, increased intake of dietary iron is a primary 
risk factor in those with genetic abnormalities that predispose them to iron overload, 
for example, in those with haemochromatosis. Most cases of haemochromatosis are 
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caused by a HFE (high iron) mutant genotype. In those who have homozygous or 
heterozygous mutations of the C282Y or H63D alleles (approximately 0.4% 
Caucasians carry a homozygous C282Y mutation, and 6% a heterozygous C282Y 
mutation), risk of clinically significant iron overload is increased, therefore caution 
should be applied with supplementation (Hollerer, Bachmann, & Muckenthaler, 
2017). In one study, HFE gene mutations were present in over 80% (37 of 46) of 
international gold medalists in endurance sports (Hermine et al., 2015) suggesting 
some performance advantage associated with this gene mutation. 
 
  Since certain nutrients can facilitate or inhibit iron absorption (see above), it is 
generally recommended to take iron supplements away from meals and in 
combination with vitamin C (Reddy et al., 2000).  Absorption from oral supplements 
can be slow and the supplements often cause side effects such as constipation, and 
abdominal discomfort/cramps. It has recently been shown that supplementing with 
Vitamin D3 significantly reduced hepcidin concentration in Vitamin D deficient but 
otherwise healthy adults (Smith et al., 2017), indicating the potential for a 
downstream effect on iron status. Such indirect means of addressing iron deficiency, 
without the aforementioned side effects, is an important area of future research. 
 
Parenteral Iron  
 
  In clinical settings under the guidance of a physician, intravenous iron injections are 
used where a more rapid repletion of iron stores is required, for example when IDA is 
diagnosed prior to a major competition (Pedlar et al., 2013).  Injections have proven 
successful across a variety of patient groups at improving iron status, haematological 
indices and subjective fatigue (Krayenbuehl et al. 2011). To date, investigations 
utilising iron injections as interventions for iron deficient athletes in randomised 
control trial designs are sparse (Blee et al., 1999; Burden et al., 2015; Peeling et al., 
2007) and therefore the understanding of the acute and chronic effects of injection in 
athletes is limited. However, the use of injection interventions, rather than oral 
treatment, for IDNA athletes is supported by investigations comparing oral vs. 
injection treatments in highly trained male and female distance runners (Garvican et 
al., 2014) and other endurance sports (Peeling et al., 2007). Both studies showed 
iron injections to be more effective than oral supplementation at rapidly improving 
iron status.  
 
Recommendations  
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  Causes of fatigue including an underlying illness or pathological condition, sleep 
irregularities, non-sport factors i.e. work, education, family, social commitments and 
the crucial balance between exercise workload and recovery should be considered 
and excluded alongside haematological screening for iron deficiency.  This screening 
should include measures of red cell number and health, iron status and tHb-mass.  
Best practice requires a longitudinal approach, where serial measures of iron and red 
cell indices are monitored to provide a trajectory for each system.  
 
  If IDA is indicated (sFer < 15 µg.L-1; [Hb] <120 g.L-1 and/or tHb-mass is trending 
lower than would be considered normal for that individual), then treatment is 
recommended and the athlete should seek medical advice as to the dose and 
protocol. 
 
  If IDNA is suspected i.e. sFer < 35 µg.L-1 but all other haematology is normal, then a 
review of the athlete’s historical haematological and iron status data should be made 
to help understand what is normal for that individual in the context of factors affecting 
iron balance (Figure 1; Table 1).  
 
  In all cases, the athlete should seek a nutrition consult to review and develop 
dietary practices. If a change in dietary practice has been in place this should be 
followed up with repeat haematology screens.  Monitoring the athlete with exercise 
physiology and tHbmass tests in addition to the haematology provides a 
comprehensive understanding of the ongoing efficacy of the intervention.   
 
  If fatigue persists and the potential contributing factors mentioned above have been 
explored then treatment could be considered with medical advice sought for the 
appropriate protocol and dose. Longitudinal tracking of the athlete’s haematology, 
iron status and exercise physiology should continue. 
 
  Controlled studies assessing the efficacy of dietary iron intake in female athletes 
taking into account female hormones, menstrual blood losses, training 
volume/intensity and environmental factors are needed.   
 
Conclusions 
 
  Many factors can impact the iron balance in female athletes, including training, 
dietary intake, altitude training, menstruation and pregnancy. Understanding how 
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these influence iron status is essential. Iron deficiency anaemia will reduce 
endurance performance via impaired oxygen transport and should be clinically 
treated. Intravenous injections and oral supplementation are effective treatments for 
IDA. Questions remain over the impact of IDNA and whether or not iron treatment is 
appropriate for this condition. Longitudinal monitoring of an athlete’s haematology 
and iron status during periods of treatment and non-treatment will help to clarify the 
efficacy of supplementation for the female athlete. 
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Table titles: 
Table 1: A conceptual formula describing factors influencing iron balance as it 
pertains to endurance performance. 
 
Figure titles:  
Figure 1. The effect or predicted effect of various scenarios upon iron status, total 
haemoglobin mass and hepcidin, demonstrating the importance of context when 
interpreting athlete data.  *Hepcidin responses are largely theoretical since few data 
have been published in athletes. 
Figure 2. A process for identifying and correcting iron deficiency in fatigued female 
athletes.  
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Table 1: A conceptual formula describing factors influencing iron balance as it 
pertains to endurance performance.  
Diet (A) + Absorption ( ) + Exercise Stimulus (C) + Genes (D) + Environment (E) + Iron 
loss () = Hb mass (G) + Non Hb iron → Endurance Performance Phenotype (H) 
 
Where: 
 
Influenced by: 
In athlete’s 
control?  
A = Diet ± Dietary intake vol. and freq. (heme and non-heme 
sources) 
+ Absorption enhancers (Vit C, Vit A, β-carotene) 
 − Transport inhibitors (Phenolic acids (tannins); 
certain polyphenols; Phytates; antacid therapy) 
Yes 
‘What you 
consume 
and when’ 
B  = Rate of iron 
absorption 
± Absorption rate of dietary iron in the gut 
 
No 
C = Duration and 
frequency of exercise  
 
+ Stimulates erythropoiesis 
− Inflammation* 
− Reduced visceral blood flow 
− Sweating 
Yes 
‘What you 
do’ 
D = Genes controlling 
related physiology  
 
+ HFE gene mutation  
+ HIF1ɑ 
+ EPO 
+ Iron   
− Menstrual blood loss 
− Sweat rate 
− Hepcidin* 
Compensatory mechanisms: 
+ Population dynamics (lowering Vc) 
+ Plasma volume expansion 
+ oxygen dissociation curves, P50, 2,3,DPG 
No 
‘What you are’ 
E = Environment 
 
+ Hypoxia (Acclimatisation) 
− Haemolysis (surface & sport modality) 
− Sweating 
Yes 
‘Where you 
are’ 
 
F 	= Rate of iron loss 
± Red cell clearance threshold (Vc) 
− Excretion 
− Sweating 
± Neocytolysis 
No 
G = Hbmass Total capacity for gas exchange  
H = Endurance 
Performance 
G + Central (e.g. cardiac output) + Peripheral (e.g. 
mitochondrial density) 
 
Where: +  = increases or improves 
−  = decreases or compromises 
±  = increases or decreases 
→ = leads to, or results in 
 
Abbreviations: vol. = volume; freq. = frequency; Vit C = vitamin C; Vit A = vitamin A; HFE = 
high iron; HIF1α = hypoxia inducible factor 1 alpha; EPO = erythropoietin; Vc = red blood cell 
clearance threshold; P50 = the affinity of haemoglobin for oxygen, specifically the pressure of 
oxygen at which the haemoglobin is 50% saturated; 2,3DPG = 2,3-Bisphosphoglyceric acid;  
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Figure 1. The effect or predicted effect of various scenarios upon iron status, total haemoglobin mass and 
hepcidin, demonstrating the importance of context when interpreting athlete data.  *Hepcidin responses are 
largely theoretical since few data have been published in athletes.  
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Figure 2. A process for identifying and correcting iron deficiency in fatigued female athletes.  
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